Title : Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours.

Pub. Date : 1992

PMID : 1382492






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After the addition of IFN-alpha, 17 of the 22 patients (77%) with elevated urinary 5-hydroxyindoleacetic acid showed a significant (> 50%) reduction. Hydroxyindoleacetic Acid interferon alpha 1 Homo sapiens
2 Thus, the addition of IFN-alpha is beneficial for patients with malignant carcinoid tumours that progress and/or who do not respond to octreotide. Octreotide interferon alpha 1 Homo sapiens